U.S. FDA authorizes Novavax's COVID vaccine as booster for adults

U.S. FDA authorizes Novavax's COVID vaccine as booster for adults The U.S. Food and Drug Administration on Wednesday authorized Novavax Inc's COVID-19 vaccine as a booster for adults, helping the company's shares reverse course and rise more than 3%. Reuters Reuters

...

The authorization applies for people unable to get updated Omicron-tailored boosters, or those who would choose not to receive any other booster dose.

...